KRAS and pancreatic neoplasm: Furthermore, three reports (51–53) showed that in KRAS-driven cancers such as pancreatic cancer, RAF/MEK/ERK kinase cascade and the autophagy pathways cooperate to maintain tumor survival and, as such, the combined inhibition of both pathways was highly efficacious at inhibiting tumor growth.